Switching Rexulti from Evening to Morning Dosing
Direct Recommendation
For most patients, you can switch Rexulti from 5pm to morning administration immediately without any titration period or gradual transition. 1, 2
Rationale for Immediate Switch
- Brexpiprazole (Rexulti) has a long elimination half-life of approximately 91 hours, which means steady-state blood levels are maintained throughout the day regardless of exact dosing time 1
- The extended half-life provides a pharmacokinetic buffer that prevents significant fluctuations in drug levels when switching administration times 2
- Clinical trials have demonstrated that brexpiprazole can be administered once daily at any time of day with consistent efficacy and tolerability 1, 2
Practical Implementation Algorithm
Step 1: Assess Current Tolerability
- If the patient is experiencing sedation or somnolence with evening dosing, morning administration may actually worsen daytime functioning 1
- If the patient has insomnia or activation with evening dosing, morning administration is likely to improve tolerability 3
Step 2: Execute the Switch
- Simply take the next scheduled dose in the morning instead of at 5pm 1
- No dose reduction, splitting, or overlap period is necessary 2
- Maintain the same total daily dose (typically 2-4 mg for schizophrenia) 1, 2
Step 3: Monitor for 1-2 Weeks
- Watch for changes in sedation patterns, particularly if the patient had been tolerating evening dosing well 3
- Assess for any emergence or worsening of akathisia, though brexpiprazole has a relatively low incidence (5.5% in schizophrenia trials) compared to other dopamine partial agonists 2
- Monitor sleep quality, as the timing change may affect sleep architecture differently than the previous evening dose 3
Critical Considerations Based on Side Effect Profile
- Brexpiprazole exhibits stronger antihistaminic activity than aripiprazole, which contributes to sedative effects 3
- If sedation has been problematic, switching to morning dosing may interfere with daytime functioning and work performance 3
- The drug's relatively low propensity for activating adverse events means that morning dosing is unlikely to cause significant agitation or restlessness 1
Common Pitfalls to Avoid
- Do not gradually transition by splitting doses or taking partial doses at different times - this is unnecessary given the long half-life and may confuse the patient 1
- Do not reduce the dose when switching times unless there are specific tolerability concerns unrelated to timing 2
- Do not overlap doses (taking both evening and morning doses) as this would constitute a double dose and increase risk of adverse effects 1
- Do not assume that all patients will tolerate morning dosing better - some patients may have been strategically dosed in the evening to leverage sedative effects for sleep 3
When to Reconsider the Switch
- If the patient experiences increased daytime sedation that impairs functioning after 1-2 weeks, consider switching back to evening dosing 3
- If new-onset insomnia develops with morning dosing, this may indicate the drug's activating properties are more prominent in this individual 1
- Weight gain and metabolic parameters should continue to be monitored regardless of dosing time, as these are not timing-dependent effects 2